Literature DB >> 27789285

The role of microRNAs in liver injury at the crossroad between hepatic cell death and regeneration.

Volker M Lauschke1, Souren Mkrtchian2, Magnus Ingelman-Sundberg2.   

Abstract

The liver fulfills critical metabolic functions, such as controlling blood sugar and ammonia levels, and is of central importance for lipid metabolism and detoxification of environmental and chemical agents, including drugs. Liver injuries of different etiology can elicit a spectrum of responses. Some hepatocytes initiate molecular programs resulting in cell death, whereas others undergo cellular divisions to regenerate the damaged organ. Interestingly, recent research indicates that microRNAs serve as very rapid as well as long-term regulators in these processes. In this review, we discuss their importance in liver disease etiology and progression as well as for therapy with particular focus on metabolic and inflammatory conditions. Furthermore, we highlight the central role of microRNAs in controlling hepatocyte differentiation and plasticity, which are required for successful regeneration, but under certain conditions, such as chronic liver insults, can result in the formation of hepatocellular carcinoma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dedifferentiation; Fatty liver; Liver disease; Plasticity; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27789285     DOI: 10.1016/j.bbrc.2016.10.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  MicroRNA-183 accelerates the proliferation of hepatocyte during liver regeneration through targeting programmed cell death protein 6.

Authors:  Fangxing Hou; Xing Li; Yanfeng Wang; Xiangzuo Xiao
Journal:  Genes Genomics       Date:  2022-02-21       Impact factor: 2.164

Review 2.  Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis.

Authors:  Andrea Iorga; Lily Dara; Neil Kaplowitz
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

3.  Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.

Authors:  Catherine C Bell; Volker M Lauschke; Sabine U Vorrink; Henrik Palmgren; Rodger Duffin; Tommy B Andersson; Magnus Ingelman-Sundberg
Journal:  Drug Metab Dispos       Date:  2017-01-30       Impact factor: 3.922

Review 4.  "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.

Authors:  Marcial Sebode; Lisa Schulz; Ansgar W Lohse
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

5.  Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway.

Authors:  Jiena Ye; Jiawen Zheng; Xiaoxiao Tian; Baogui Xu; Falei Yuan; Bin Wang; Zuisu Yang; Fangfang Huang
Journal:  Mar Drugs       Date:  2022-03-25       Impact factor: 6.085

6.  An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension.

Authors:  Zhixiong Mei; Baoqin Huang; Ying Mo; Jianhui Fan
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

7.  Large-Scale Profiling of Signaling Pathways Reveals a Distinct Demarcation between Normal and Extended Liver Resection.

Authors:  Pieter Borger; Anton Buzdin; Maksim Sorokin; Ekaterina Kachaylo; Bostjan Humar; Rolf Graf; Pierre-Alien Clavien
Journal:  Cells       Date:  2020-05-07       Impact factor: 6.600

8.  Brg1 regulates murine liver regeneration by targeting miR-187-5p dependent on Hippo signalling pathway.

Authors:  Junhua Gong; Tong Mou; Hao Wu; Zhongjun Wu
Journal:  J Cell Mol Med       Date:  2020-08-26       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.